COMMUNIQUÉS West-GlobeNewswire

Adverse Effects of COVID Vaccine on Musculoskeletal Conditions Need Research, according to the Journal of American Physicians and Surgeons
02/06/2026
TUCSON, Ariz., June 02, 2026 (GLOBE NEWSWIRE) -- The contentious issue of musculoskeletal adverse effects of COVID-19 vaccines arises in the context of the collapse of public trust in academic expertise, writes Jane M. [...]
AB Science : Stonegate Capital Partners updates its coverage of AB Science’s stock with a target price of EUR 4.25 per share
02/06/2026
PRESS RELEASE STONEGATE CAPITAL PARTNERS UPDATES ITS COVERAGE OF AB SCIENCE’S STOCK WITH A DISCOUNTED CASH FLOW VALUATION MID-POINT OF EUR 4.25 PER SHARE Paris, June 2 nd , 2026, 6pm CET AB Science SA (Euronext - [...]
Update on the Carbios - Wankai project in China
02/06/2026
Clermont-Ferrand (France), 2 June 2026 (05:45 pm CEST). Carbios (Euronext Growth Paris: ALCRB) provides an update on the progress of its strategic partnership with Wankai New Materials (“ Wankai ”) in the field of PET [...]
NexTel Medical Corp. Executes Definitive Purchase Agreements to Acquire JumpstartRx and NueVistraMed, Expanding Telehealth Footprint and Accelerating Maxasome™ Commercialization
02/06/2026
Acquisitions bring immediate $135,000 in monthly recurring revenue prior to near-term scaling initiatives; Transaction structured as non-dilutive to $MAJI shareholders. ORLANDO, Fla., June 02, 2026 (GLOBE NEWSWIRE) -- [...]
GENFIT Annual General Meeting of June 15, 2026 - Shareholders' letter
02/06/2026
Dear Shareholders, We are pleased to send you, in the attached document, GENFIT’s Shareholders’ Letter published ahead of our Annual General Meeting to be held on June 15, 2026. This letter outlines the key elements [...]
Physicians Subjected to Unreliable ‘Lie-Detector’ Tests, according to the Journal of American Physicians and Surgeons
02/06/2026
TUCSON, Ariz., June 02, 2026 (GLOBE NEWSWIRE) -- Although polygraphs (“lie-detector” tests) are considered too unreliable to be admissible in federal and most state courts, physicians are often being forced to submit to [...]
Zealand Pharma to participate in the Goldman Sachs Global Healthcare Conference
02/06/2026
Press release – No. 12 / 2026 Zealand Pharma to participate in the Goldman Sachs Global Healthcare Conference Copenhagen, Denmark, June 2, 2026 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology [...]
FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for Patients
02/06/2026
Guidance shows how sponsors can build on existing science, reducing redundant testing and accelerating treatments for patients with rare and life-threatening diseases Silver Spring, MD, June 02, 2026 (GLOBE NEWSWIRE [...]
GENFIT : Assemblée Générale Mixte du 15 juin 2026 - Lettre aux actionnaires
02/06/2026
Chers Actionnaires, Nous avons le plaisir de vous adresser, en pièce jointe, la Lettre aux actionnaires de GENFIT publiée à l’approche de notre Assemblée Générale Mixte du 15 juin 2026. Cette lettre revient sur les [...]
Oraticx Expands Oral Probiotics Lineup for Daily Oral Care and Oral Microbiome Wellness
02/06/2026
New product range introduces targeted probiotic oral care solutions for everyday wellness routines Oraticx Logo LOS ANGELES, June 02, 2026 (GLOBE NEWSWIRE) -- Oraticx, a wellness brand focused on oral microbiome balance [...]
Jersey College Offers Associate Degree for NJ Nursing Students With and Without Prior Licensure
02/06/2026
Teterboro and Ewing campuses offer full ADN program. Next class starts August 17. TETERBORO, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- Jersey College , the institution dedicated to excellence in nursing education, [...]
Scene Health Releases New Guide on Medication Adherence Support for Leaders Advancing Rural Health Transformation
02/06/2026
BALTIMORE, June 02, 2026 (GLOBE NEWSWIRE) -- Scene Health announces the release of its new guide, Transforming Rural Healthcare through Medication Adherence Support , designed for U.S. health leaders strengthening their [...]
Inventiva Announces Trading Resumption of its Ordinary Shares on Euronext Paris
02/06/2026
Daix (France), New York City (New York, United States), June 2, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA ) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of [...]
Oncolytics Biotech® Announces Appointment of Steve Glover to Board of Directors and Promotion of John McAdory to Chief Operating Officer
02/06/2026
SAN DIEGO, June 02, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage company developing pelareorep, an investigational, systemically active [...]
Signati™ Medical Receives FDA IDE Approval for Pivotal Study of the Separo™ Vessel Sealing System
02/06/2026
Providence, RI, June 02, 2026 (GLOBE NEWSWIRE) -- Signati™ Medical, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s Investigational Device Exemption (IDE) application for [...]
Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website
02/06/2026
New dashboard at betabionics.com shows every patient, every baseline, every outcome, with no filters and no fine print IRVINE, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering [...]
MAPS Publishes First-of-Its-Kind Literature Review on Psychedelic Healing for People Impacted by the Criminal Legal System
02/06/2026
“Relocating the Root” is a scoping literature review on the mental health needs of people directly impacted by the criminal legal system Publishing this literature review launches a project that builds on nearly four [...]
MAIA Biotechnology Announces Open Market Purchases by CEO and Director
02/06/2026
CHICAGO, June 02, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, [...]
Kura Oncology and Kyowa Kirin Announce Publication in Blood of Ziftomenib plus Venetoclax / Azacitidine Combination in Patients with R/R NPM1-m AML
02/06/2026
– 87% ORR and 70% CRc in venetoclax-naïve and 48% ORR and 24% CRc in venetoclax-experienced patients at the recommended 600 mg once-daily dose – – Central MRD negativity in 75% of CRc responders with no prior venetoclax [...]

Pages